UMTC - Company finances
|
EUR
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|
|
Financial data
|
|||||
| Sales revenue | 87,254 | 133,151 | 187,526 | 277,395 | 326,437 |
| Profit before tax | - | 33,191 | 60,904 | 72,502 | 65,006 |
| Net profit | 10,232 | 33,191 | 60,904 | 72,502 | 54,527 |
| Equity | 39,438 | 73,209 | 133,374 | 204,871 | 269,877 |
| Liabilities | 12,253 | 17,965 | 18,407 | 13,019 | 25,985 |
| Non-current assets | 0 | 3,880 | 7,776 | 51,701 | 61,315 |
| Current assets | 51,691 | 87,294 | 144,005 | 166,189 | 267,488 |
| Total assets | 51,691 | 91,174 | 151,781 | 217,890 | 328,803 |
|
Taxes paid
|
|||||
| STI taxes | - | - | 23,205 | 44,876 | 47,444 |
| Social insurance contributions | - | - | 26,956 | 41,494 | 53,837 |
|
Financial indicators
|
|||||
| Revenue change y/y | - | +52.6% | +40.8% | +47.9% | +17.7% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 19.8% | 36.4% | 40.1% | 33.3% | 16.6% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 25.9% | 45.3% | 45.7% | 35.4% | 20.2% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 11.7% | 24.9% | 32.5% | 26.1% | 16.7% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | 24.9% | 32.5% | 26.1% | 19.9% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.3 | 0.2 | 0.1 | 0.1 | 0.1 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 6,123 | 8,684 | 11,140 | 12,902 | 9,769 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
UMTC - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-05-17 | 2026-05-27 | 4967.66 |
| 2024-09-17 | 2024-10-01 | 2469.67 |
| 2023-11-16 | 2024-01-11 | 2.38 |
| 2023-11-13 | 2023-11-13 | 2.38 |
| 2023-10-26 | 2023-11-12 | 0.33 |
| 2023-10-25 | 2023-10-25 | 1.12 |
| 2023-10-17 | 2023-10-24 | 0.33 |
| 2023-05-16 | 2023-06-12 | 0.33 |
| 2023-05-02 | 2023-05-09 | 0.33 |
| 2023-04-18 | 2023-04-28 | 0.33 |
| 2023-03-16 | 2023-04-10 | 0.33 |
| 2023-02-17 | 2023-03-07 | 0.33 |
UMTC - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-07-07 | 2026-08-03 | 5.44 |
| 2026-07-02 | 2026-07-06 | 5.1 |
| 2026-06-30 | 2026-07-01 | 1269.17 |
| 2026-06-18 | 2026-06-29 | 1290.64 |
| 2025-07-24 | 2025-08-10 | 1.92 |
| 2025-07-03 | 2025-07-23 | 1.68 |
| 2025-07-01 | 2025-07-02 | 461.96 |
| 2025-06-19 | 2025-06-30 | 460.28 |
| 2025-02-28 | 2025-06-18 | 0.28 |
| 2024-10-03 | 2025-02-27 | 0.4 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
UMTC, UAB (code 183246917) is a private limited liability company engaged in medical specialists activities. In the latest financial year, 2025, the company generated revenue of €326.4K and net profit of €54.5K, with a profit margin of 16.7%. Revenue continued to expand, rising from €187.5K in 2023 to €277.4K in 2024 and €326.4K in 2025, which indicates sustained top-line growth over the three-year period. Profitability remained positive throughout the period, although net profit declined from €72.5K in 2024 after a stronger 2024 result. The balance sheet strengthened further in 2025, with total assets of €328.8K and equity of €269.9K, compared with liabilities of €26.0K. This resulted in a high equity ratio of 82.1% and a debt-to-equity ratio of 0.10, pointing to a conservative capital structure. Asset turnover stood at 0.99x, while ROE was 20.2% and ROA 16.6%. Revenue per employee was €9.9K and profit per employee €1.7K in 2025.